{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:48:36Z","timestamp":1761392916631},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T00:00:00Z","timestamp":1221782400000},"content-version":"vor","delay-in-days":2394,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Peripheral Nervous Sys"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p><jats:bold>Abstract\u2003<\/jats:bold> This study is designed to establish whether sialosylneolactotetraosylceramide (LM1), a major component of human peripheral nerve ganglioside, is a potential target antigen for the development of peripheral autoimmune neuropathies such as Guillain\u2010Barr\u00e9 syndrome (GBS) and Miller Fisher syndrome (MFS). Serum antibodies against LM1 in 116 patients with GBS, 56 patients with MFS, 88 patients with motor neuron disease (MND) and 60 normal control subjects were quantified using enzyme\u2010linked immunosorbent assay (ELISA). The presence of anti\u2010LM1 antibodies were confirmed using an immunostaining method on high\u2010performance thin\u2010layer chromatographic plates (HPTLC). Anti\u2010LM1 IgG antibodies were detected in 22% (25\/116) of patients with GBS. The ratio of the demyelination type to the axonal type of GBS was approximately 3:1. Among the 25 anti\u2010LM1\u2010positive GBS patients, additional anti\u2010GM1 IgG antibodies were detected in 7 patients, 4 of whom possessed the axonal form of GBS. Anti\u2010LM1 antibodies were also detected in a significant portion of patients with MFS (20%, 11\/56). In contrast, anti\u2010LM1 antibodies were detected in only 2% (2\/88) of patients with MND, and 7% (4\/60) of normal control subjects. The results of this study suggest that serum antibodies against LM1 may have a pathogenic role in the development of GBS and MFS.<\/jats:p>","DOI":"10.1046\/j.1529-8027.2002.02006.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T07:18:21Z","timestamp":1047453501000},"page":"54-58","source":"Crossref","is-referenced-by-count":8,"title":["Anti\u2010LM1 antibodies in the sera of patients with Guillain\u2010Barr\u00e9 syndrome, Miller Fisher syndrome, and Motor Neuron Disease"],"prefix":"10.1111","volume":"7","author":[{"given":"Hajime","family":"Harukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiide","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,9,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1016\/S0021-9258(17)39945-3","article-title":"Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain.","volume":"252","author":"Ando S","year":"1977","journal-title":"J Biol Chem"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310619"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.10.1911"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01123-7"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315684"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/118.3.597"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230503"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90217-9"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350217"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350510"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/S0021-9258(19)44156-2","article-title":"Structure of the major glucosamine containing ganglioside of human tissues.","volume":"248","author":"Li Y\u2010T","year":"1973","journal-title":"J Biol Chem"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(95)00101-7"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb11018.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240113"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880141002"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270710"},{"key":"e_1_2_6_19_1","first-page":"841","article-title":"Guillain\u2010Barr\u00e9 syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features.","volume":"118","author":"Visser LH","year":"1995","journal-title":"Dutch Guillain-Barr\u00e9 Study Group. Brain"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.2.204"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90042-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00174-4"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000116872"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00280-5"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-5955-6_1"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.12.1900"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.2.414"},{"key":"e_1_2_6_28_1","first-page":"891","article-title":"Proximal lower motor neuron syndrome associated with serum antibodies to asialo\u2010GM1, GM1 and LM1.","volume":"33","author":"Yuki N","year":"1993","journal-title":"Clin Neurol (Tokyo)"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(96)00042-2"}],"container-title":["Journal of the Peripheral Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1529-8027.2002.02006.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1529-8027.2002.02006.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:25:29Z","timestamp":1694431529000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1529-8027.2002.02006.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1046\/j.1529-8027.2002.02006.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1529-8027.2002.02006.x","archive":["Portico"],"relation":{},"ISSN":["1085-9489","1529-8027"],"issn-type":[{"value":"1085-9489","type":"print"},{"value":"1529-8027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}